Behavioural, Biochemical, Proteomics Studies And Replacement Therapy Of Morphine And Mitragynine Withdrawal Rat Models

dc.contributor.authorHassan, Rahimah
dc.date.accessioned2022-07-27T07:31:51Z
dc.date.available2022-07-27T07:31:51Z
dc.date.issued2021-01
dc.description.abstractThe current study was designed to test the ability of mitragynine to attenuate behavioural signs of morphine-withdrawal in a rat model in comparison to methadone and buprenorphine. A six-day treatment with escalating dose of morphine (10-50 mg/kg, i.p.) induced profound withdrawal signs for 16 days.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/15660
dc.language.isoenen_US
dc.publisherUniversiti Sains Malaysiaen_US
dc.subjectBehaviouralen_US
dc.subjectBiochemicalen_US
dc.subjectProteomicsen_US
dc.subjectReplacement Therapy Of Morphineen_US
dc.subjectWithdrawal Rat Modelsen_US
dc.titleBehavioural, Biochemical, Proteomics Studies And Replacement Therapy Of Morphine And Mitragynine Withdrawal Rat Modelsen_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: